Sam L Barker insider trades

Open-market stock purchases and sales by Sam L Barker, Director at Lexicon Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 30, 2010.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +29%.

Recent trades

DateStockTradeValue
Jun 3, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
May 1, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
May 1, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—

Companies traded

  • LXRX Lexicon Pharmaceuticals, Inc: 2 buys, last Jun 3, 2026
  • CYCC Cyclacel Pharmaceuticals, Inc: 2 buys, 1 sale, last Jun 30, 2023
  • CADX Cadence Pharmaceuticals Inc: 1 buy, last Mar 19, 2014

Get free alerts when Sam L Barker files a new trade →